TESS
DeviceSmall stimulation pulses will be given to the spine at C5-6 in a non invasive manner.
Other names: NeoStim-5
NCT Number: NCT05157282
In support of the long-term goal of developing new strategies to increase limb function after SCI, the objectives of this proposal are to: 1) Examine the behavioral and physiological effects of TESS on upper-limb muscles after cervical SCI; and 2) Maximize the recovery of reaching and grasping potential by using tailored TESS in a task-specific manner with motor training. Veterans with cervical spinal injuries and healthy volunteers will be recruited for this study.
Interested in participating?
Request Info18 year–70 year
All sexes
Interventional
Not applicable
Shirley Ryan AbilityLab, Chicago, Illinois, United States
Current studies demonstrate that electrical spinal stimulation, either invasive or noninvasive, can play an important role in rehabilitation strategies aimed at improving limb function in humans with SCI (Taccola et al., 2018). Among current stimulation strategies, one of the most promising candidates to emerge in recent years is transcutaneous electrical spinal stimulation (TESS). TESS is a noninvasive technique that can be tailored to the needs of each individual, where several segments of the spinal cord can be stimulated at the same time, and delivery can be programed to interact with a rehabilitation strategy during functional movements, such as reaching or grasping. A key element to TESS is its ability to access spared spinal cord networks with minimal discomfort. Although promising, the knowledge of TESS remains limited in scope and more studies are needed to further identify its efficacy.
In Aim 1, subjects will participate in two randomized sessions: 1) TESS, and 2) sham-TESS.] In Aim 2, the investigators will examine the effect of stimulation and training for a total of 20 sessions (3 to 5 per week). Participants will be randomly assigned to: [1) Closed-loop TESS applied during grasping + training, or 2) Closed-loop TESS applied during reaching + training.]
AIM 1 Subjects with SCI and without SCI (controls) will participate in two testing sessions, separated by 2-3 days, using a crossover design. In each session, TESS or sham-TESS will be applied over the cervical spinal cord. Functional and physiological measures will be acquired before and after each session.
AIM 2 Develop methodologies to promote recovery of reaching and grasping movements. To accomplish this goal, the investigators will combine TESS applied in a closed-loop manner with massed practice upper-limb training. Participants will be assigned to one of three groups in a randomized order using a sham controlled design: [1) Closed-loop TESS applied during grasping + training, 2) Closed-loop TESS applied during reaching + training, and 3) Closed-loop TESS applied during grasping & reaching + training.] TESS for 20-min will be followed by 60 min of massed practice exercise training (total=20 sessions).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Inclusion criteria
for SCI:
Inclusion criteria
for controls:
Exclusion criteria
Exclusion criteria
for SCI and control subjects:
Small stimulation pulses will be given to the spine at C5-6 in a non invasive manner.
Other names: NeoStim-5
The participant will be instructed to do repetitive motor movements with their arm or hand.
Other names: Massed Practice Training
Participants will be asked to perform specific motor tasks or movements with their fingers, hands, and arms.
Small sham stimulation pulses will be given to the spine at C5-6 in a non invasive manner.
Other names: NeoStim-5
Time frame: Change from baseline at study completion, average of 5 weeks
Ten stimuli (0.2 Hz) will be delivered at each intensity to plot the mean peak-to-peak amplitude of the MEP from the non-rectified response against the TMS intensity in each subject (MEP recruitment curve).
Time frame: Through study completion(average of 5 weeks) and during 6-month follow-up
The GRASSP will be used to asses several domains of arm/hand function in humans with cervical SCI, specifically assessing three domains of hand function: 1) strength, 2) sensibility, and 3) prehension. The time to administer the test is ~45 min. The GRASSP has 5 subsets:
Time frame: Change from baseline at study completion, average of 5 weeks
Ten Transcranial magnetic stimuli (TMS) will be delivered to plot the mean peak-to-peak amplitude of the motor and cervicomedullary evoked potentials (MEPs and CMEPs, respectively) from the non-rectified response against the TMS intensity in each subject (MEP/CMEP recruitment curves).
Contact information is provided by the study sponsor or research team.
VA Office of Research and Development
Fed
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06836739
Central Nervous System Diseases, Colonic Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT07245706
Central Nervous System Diseases, Injury
Nottwil, Canton of Lucerne, Switzerland
View Trial DetailsNCT07720882
Central Nervous System Diseases, Nervous System Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT07692191
Back Injuries, Behavior
Winnipeg, Manitoba, Canada
View Trial Details